Healthcare Stocks Jump: Drug Pricing Deal?

Healthcare stocks unexpectedly surged after a potential White House drug-pricing deal surfaced, with Pfizer reportedly agreeing to lower Medicaid prices. AbbVie and AMN Healthcare led the gains, but analysts remain cautious, especially on AMN, which has seen significant volatility and price target reductions. Is this a buying opportunity or a sign of deeper troubles in the pharmaceutical sector? Hosted on Acast. See acast.com/privacy for more information.